vs
Side-by-side financial comparison of Confluent, Inc. (CFLT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $314.8M, roughly 1.6× Confluent, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -25.2%, a 32.0% gap on every dollar of revenue. On growth, Confluent, Inc. posted the faster year-over-year revenue change (20.5% vs -1.7%). Over the past eight quarters, Confluent, Inc.'s revenue compounded faster (20.4% CAGR vs -0.1%).
Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
CFLT vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $314.8M | $493.8M |
| Net Profit | $-79.2M | $33.7M |
| Gross Margin | 74.7% | — |
| Operating Margin | -31.5% | 9.9% |
| Net Margin | -25.2% | 6.8% |
| Revenue YoY | 20.5% | -1.7% |
| Net Profit YoY | 10.0% | 10.5% |
| EPS (diluted) | $-0.23 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $314.8M | $493.8M | ||
| Q3 25 | $298.5M | $492.9M | ||
| Q2 25 | $282.3M | $468.8M | ||
| Q1 25 | $271.1M | $458.4M | ||
| Q4 24 | $261.2M | $502.4M | ||
| Q3 24 | $250.2M | $511.2M | ||
| Q2 24 | $235.0M | $504.3M | ||
| Q1 24 | $217.2M | $495.1M |
| Q4 25 | $-79.2M | $33.7M | ||
| Q3 25 | $-66.5M | $71.7M | ||
| Q2 25 | $-82.0M | $39.3M | ||
| Q1 25 | $-67.6M | $20.7M | ||
| Q4 24 | $-88.1M | $30.5M | ||
| Q3 24 | $-74.1M | $19.4M | ||
| Q2 24 | $-89.9M | $-153.0M | ||
| Q1 24 | $-93.0M | $4.0M |
| Q4 25 | 74.7% | — | ||
| Q3 25 | 74.2% | — | ||
| Q2 25 | 73.7% | — | ||
| Q1 25 | 74.5% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 74.5% | — | ||
| Q2 24 | 72.3% | — | ||
| Q1 24 | 71.8% | — |
| Q4 25 | -31.5% | 9.9% | ||
| Q3 25 | -27.9% | 13.8% | ||
| Q2 25 | -34.2% | 12.8% | ||
| Q1 25 | -37.3% | 7.0% | ||
| Q4 24 | -40.5% | 7.8% | ||
| Q3 24 | -37.4% | 6.6% | ||
| Q2 24 | -46.1% | -31.3% | ||
| Q1 24 | -51.3% | 3.2% |
| Q4 25 | -25.2% | 6.8% | ||
| Q3 25 | -22.3% | 14.5% | ||
| Q2 25 | -29.0% | 8.4% | ||
| Q1 25 | -24.9% | 4.5% | ||
| Q4 24 | -33.7% | 6.1% | ||
| Q3 24 | -29.6% | 3.8% | ||
| Q2 24 | -38.3% | -30.3% | ||
| Q1 24 | -42.8% | 0.8% |
| Q4 25 | $-0.23 | $0.40 | ||
| Q3 25 | $-0.19 | $0.84 | ||
| Q2 25 | $-0.24 | $0.46 | ||
| Q1 25 | $-0.20 | $0.24 | ||
| Q4 24 | $-0.26 | $0.37 | ||
| Q3 24 | $-0.23 | $0.23 | ||
| Q2 24 | $-0.28 | $-1.84 | ||
| Q1 24 | $-0.30 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $347.2M | $375.2M |
| Total DebtLower is stronger | $1.1B | $570.5M |
| Stockholders' EquityBook value | $1.2B | $865.9M |
| Total Assets | $3.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.94× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $347.2M | $375.2M | ||
| Q3 25 | $298.5M | $340.1M | ||
| Q2 25 | $295.6M | $224.7M | ||
| Q1 25 | $278.6M | $99.0M | ||
| Q4 24 | $386.0M | $229.9M | ||
| Q3 24 | $322.6M | $103.8M | ||
| Q2 24 | $311.3M | $19.4M | ||
| Q1 24 | $336.4M | $8.0M |
| Q4 25 | $1.1B | $570.5M | ||
| Q3 25 | $1.1B | $577.2M | ||
| Q2 25 | $1.1B | $583.9M | ||
| Q1 25 | $1.1B | $590.5M | ||
| Q4 24 | $1.1B | $597.1M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $1.2B | $865.9M | ||
| Q3 25 | $1.1B | $890.7M | ||
| Q2 25 | $1.1B | $833.8M | ||
| Q1 25 | $1.0B | $789.2M | ||
| Q4 24 | $961.2M | $764.9M | ||
| Q3 24 | $934.3M | $732.5M | ||
| Q2 24 | $873.9M | $706.5M | ||
| Q1 24 | $845.2M | $856.2M |
| Q4 25 | $3.0B | $2.2B | ||
| Q3 25 | $2.9B | $2.2B | ||
| Q2 25 | $2.8B | $2.1B | ||
| Q1 25 | $2.7B | $2.0B | ||
| Q4 24 | $2.7B | $2.2B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.5B | $2.0B | ||
| Q1 24 | $2.4B | $2.2B |
| Q4 25 | 0.94× | 0.66× | ||
| Q3 25 | 0.98× | 0.65× | ||
| Q2 25 | 1.03× | 0.70× | ||
| Q1 25 | 1.07× | 0.75× | ||
| Q4 24 | 1.14× | 0.78× | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | $114.1M |
| Free Cash FlowOCF − Capex | $41.7M | — |
| FCF MarginFCF / Revenue | 13.2% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $60.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.1M | $114.1M | ||
| Q3 25 | $30.8M | $137.3M | ||
| Q2 25 | $18.1M | $137.2M | ||
| Q1 25 | $-26.8M | $-117.5M | ||
| Q4 24 | $35.2M | $133.0M | ||
| Q3 24 | $15.6M | $91.8M | ||
| Q2 24 | $8.6M | $107.0M | ||
| Q1 24 | $-26.0M | $-125.2M |
| Q4 25 | $41.7M | — | ||
| Q3 25 | $30.0M | — | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $-28.2M | — | ||
| Q4 24 | $34.5M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $-26.1M | — |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | -10.4% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | -12.0% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFLT
| Confluent Cloud | $169.4M | 54% |
| Post Contract Customer Support | $93.8M | 30% |
| License | $38.4M | 12% |
| Services | $13.2M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
